Proxy Results (Form 8-K)

On June 18, 2026, AdaptHealth Corp. (the "Company") held the annual meeting of stockholders (the "Annual Meeting") of the Company via live audio webcast. At the Annual Meeting, the Company's stockholders voted on three proposals, each of which is described in more detail in the Company's definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 28, 2026. At the beginning of the Annual Meeting, there were 120,652,493 shares of common stock of the Company, par value $0.0001 per share ("Common Stock") present or represented by proxy at the Annual Meeting, which represented 88.67% of the voting power of the shares of Common Stock entitled to vote at the Annual Meeting, and which constituted a quorum for the transaction of business. Holders of the Company's Common Stock were entitled to one vote for each share of Common Stock held as of the close of business on April 24, 2026, the record date for the Annual Meeting.

The stockholders of the Company voted on the following proposals at the Annual Meeting:

1. To elect nine directors for a one-year term;

2. To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and

3. A non-binding advisory vote to approve the compensation paid to the Company's named executive officers.

The voting results for each of these proposals are set forth below.

Based on the votes set forth above, each director nominee was duly elected to serve as a director until the Company's annual meeting of stockholders in 2027, or until their respective successors are duly elected and qualified, or until their earlier resignation, removal or death.